Gilead Sciences, Inc. GILD
167.47 USD -2.86 (-1.68%)
At closeNov 4, 2026, 8:33 AM EST
173.80 +6.33 +3.78%
Pre-market · Nov 4, 8:33 AM ET
167.43 Day range 172.00
116.88 52-week range 175.65
- YTD
- +36.44%
- 1 year
- +36.15%
Analyst view
Consensus: buy
Buy
Price target (mean) 172.50 +3.0% upside
Now 167.47
- Target (low)
- 131.00
- Target (mean)
- 172.50
- Target (high)
- 200.00
Ratings (0m) 28 22 buy · 5 hold · 1 sell
- Strong buy6
- Buy16
- Hold5
- Sell0
- Strong sell1
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 29
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.07 | 0.02175 – 1.27 | 1.86 | -42.5% | 8.31B | +4.9% | 17 |
| Next quarter | 2.17 | 1.90 – 2.38 | 2.03 | +7.1% | 7.47B | +7.3% | 7 |
| Current year | -0.98943 | -1.20 – -0.73 | 8.15 | -112.1% | 31.29B | +6.3% | 20 |
| Next year | 10.09 | 8.91 – 12.41 | -0.98943 | +1120.0% | 33.55B | +7.2% | 26 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 30, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 30, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Needham | Maintained | Buy | Buy |
| Oct 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 8, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 10, 2026 | HSBC | Maintained | Buy | Buy |
| Aug 5, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Aug 5, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 5, 2026 | Needham | Reiterated | Buy | Buy |
| Jul 29, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 7, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 6, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 6, 2026 | HSBC | Upgrade | Hold | Buy |
| Jun 16, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
